课题基金 / 基金详情

Revealing the Omnigenic Genetic Architecture of End Stage Renal Disease: Investigating the Cumulative Effect of Rare and Common Genetic Variants

Revealing the Omnigenic Genetic Architecture of End Stage Renal Disease: Investigating the Cumulative Effect of Rare and Common Genetic Variants
揭示终末期肾病的全基因遗传结构:研究罕见和常见遗传变异的累积效应
批准号:
410054
负责人:
Lanktree Matthew B
金额:
$46.53万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2023-09-01

项目摘要

项目成果

Lanktree Matthew B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Purpose: Kidney disease affects 1 in 10 Canadians. 35,000 Canadians currently have kidney failure needing dialysis or a kidney transplant. A cause for kidney failure is unknown in 50% of patients. Kidney disease does not make people unwell until it is adv
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessing the Omnigenic Contribution to Chronic Kidney Disease
  • 批准号:
    406224
  • 项目类别:
    Salary Programs
  • 资助金额:
    $7.01万
  • 财政年份:
    2019
  • 负责人:
    Lanktree Matthew B
  • 依托单位:
Can we predict when patients with polycystic kidney disease will develop kidney failure?
  • 批准号:
    367903
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Lanktree Matthew B
  • 依托单位:
Improving Autosomal Dominant Polycystic Kidney Disease Prognostication using Imaging, Next Generation Sequencing and Urinary Biomarkers
  • 批准号:
    362653
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $8.01万
  • 财政年份:
    2016
  • 负责人:
    Lanktree Matthew B
  • 依托单位:
海外基金